5-alpha reductase inhibitor: a new therapeutic option in the treatment of benign prostatic hypertrophy

A placebo-controlled randomized study of 60 patients over 50 years was undertaken to measure the effectiveness of finasteride in the management of BPH. Significant changes in the uterine flow rate, PSA level, mass volume and symptom severity score were noted.